Mineralys (MLYS) Sees Strong Pre-Hour Growth After Promising Clinical Trial News
The stock value of Mineralys Therapeutics, Inc. (NASDAQ: MLYS) has skyrocketed, gaining 54.37% to $16.24 in pre-market trade. This spike comes in reaction to the revelation of extremely optimistic results from the company’s latest clinical studies. Good Results from the Trial The jump in stock valuation followed the revelation of good topline data from two …
Mineralys (MLYS) Sees Strong Pre-Hour Growth After Promising Clinical Trial News Read More »